Thromboxane synthetase inhibitors as pharmacological tools: Differential biochemical and biological effects on platelet suspensions
- 1 November 1977
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 14 (5) , 897-907
- https://doi.org/10.1016/0090-6980(77)90306-9
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Endoperoxides and thromboxanes structural determinants for platelet aggregation and vasoconstrictionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977
- Selective inhibition of thromboxane A2 biosynthesis in blood plateletsNature, 1977
- Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.Journal of Clinical Investigation, 1977
- Biosynthesis of thromboxanes in human platelets. I. Characterization and assay of thromboxane systhetaseBiochemical and Biophysical Research Communications, 1977
- Action of methylxanthines and imidazole on the contractility of the terminal ileum of the guinea pigEuropean Journal of Pharmacology, 1977
- Contraction of Glycerol Extracted Fibres of Smooth Muscle by Acetylcholine and Imidazole in the Presence of a Ca-binding Microsomal Fraction from Rabbit ColonActa Physiologica Scandinavica, 1976
- Thromboxanes: Selective Biosynthesis and Distinct Biological PropertiesScience, 1976
- Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxidesNature, 1976
- ISomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albuminBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acidInflammation Research, 1975